42 results on '"A. Bearz"'
Search Results
2. Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor
3. ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC)
4. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
5. Tomotherapy after Pleurectomy/Decortication or Biopsy for Malignant Pleural Mesothelioma Allows the Delivery of High Dose of Radiation in Patients with Intact Lung
6. First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer: Analysis of the Italian Patients Enrolled in the SAiL Study
7. First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer: Analysis of the Italian Patients Enrolled in the SAiL Study
8. First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer: Analysis of the Italian Patients Enrolled in the SAiL Study
9. Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases
10. Small Cell Lung Cancer in an Elderly Patient: Efficacy of Somatostatin Analog Treatment, a Case Report
11. HIV-Positive Patients with Liver Metastases from Colorectal Cancer Deserve the Same Therapeutic Approach as the General Population
12. Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
13. Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma: an Italian multicentre retrospective analysis of 189 patient cases: PO119
14. Malignant peritoneal mesothelioma: a multicenter study on 81 cases
15. Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection
16. Retrospective analysis of the sequential use of sorafenib and sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC): V864
17. Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective
18. Clinical Presentation and Outcome of Colorectal Cancer in HIV-Positive Patients: A Clinical Case-Control Study
19. Bevacizumab plus Irinotecan-, Fluorouracil-, and Leucovorin-Based Chemotherapy with Concomitant HAART in an HIV-Positive Patient with Metastatic Colorectal Cancer
20. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy
21. FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients
22. Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma
23. Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era
24. Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients
25. Simplified gemcitabine and platin regimen in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to be proposed as neoadjuvant therapy
26. Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients
27. Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma
28. Adding Gemcitabine to Paclitaxel/Carboplatin Combination Increases Survival in Advanced Non–Small-Cell Lung Cancer: Results of a Phase II-III Study
29. Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non–Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study
30. Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
31. DOSE-FINDING STUDY OF IRINOTECAN (IRI) PLUS DOCETAXEL (D) IN PATIENTS WITH PRETREATED GASTRIC AND PANCREATIC CANCER
32. Efficacy of oxaliplatin and 5-fluorouracil in hepatocarcinoma (HCC): 1346
33. Staphylococcus cohnii septicaemia in a patient with colon cancer
34. Paclitaxel / carboplatin (PC) vs paclitaxel / carboplatin / gemcitabine (PCG) in advanced NSCLC: Preliminary results of a phase II-III study
35. Oxaliplatin (OXA) und 5-Fluorouracil (5-FU) bei Leberzellkarzinom (HCC): 2343
36. Vergleich von Wirksamkeit und Verträglichkeit des FOLFOX2-Schemas bei älteren und jüngeren Patienten mit fortgeschrittenem Kolorektalkarzinom (COL): 2195
37. INNOVATIVE CHEMOTHERAPY IN HEPATOCARCINOMA (HCC)
38. EFFICACY AND TOXICITY OF DOXIL/CAELYX( D) IN PATIENTS WITH RECURRENT EPITHELIAL OVARIAN CANCER (OC)
39. 5-FLUOROURACIL PLUS GEMCITABINE IN METASTATIC RENAL CANCER: PRELIMINARY CANCER RESULTS OF A PHASE II STUDY
40. Metastatic Colorectal Cancer (COL) in elderly patients (PTS): efficacy and tolerability of Folfox2 Regimen
41. Paclitaxel and carboplatin in combination with gemcitabine: A phase I-II trial in patients with advanced non-small-cell lung cancer
42. Adhesion to fibronectin promotes the activation of the p125FAK/Zap-70 complex in human T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.